Ceralifimod Uses, Dosage, Side Effects and more
Ceralifimod is under investigation in clinical trial NCT01226745 (Phase 2 Extension Trial in Patients With Relapsing-remitting Multiple Sclerosis (RRMS)).
| Trade Name | Ceralifimod |
| Generic | Ceralifimod |
| Ceralifimod Other Names | Ceralifimod |
| Type | |
| Formula | C27H33NO4 |
| Weight | Average: 435.564 Monoisotopic: 435.240958547 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
